Cargando…
Schizandrin B attenuates hypoxia/reoxygenation injury in H9c2 cells by activating the AMPK/Nrf2 signaling pathway
Schizandrin B exhibits prominent antioxidant and anti-inflammatory effects, and plays an important role in ameliorating myocardial ischemia/reperfusion injury. However, the underlying protective mechanisms remain to be elucidated. The aim of the present study was to explore the cardioprotective effe...
Autores principales: | Zhao, Bo, Li, Guang-Ping, Peng, Jian-Jun, Ren, Li-Hui, Lei, Li-Cheng, Ye, Hui-Ming, Wang, Zuo-Yan, Zhao, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851604/ https://www.ncbi.nlm.nih.gov/pubmed/33603829 http://dx.doi.org/10.3892/etm.2021.9651 |
Ejemplares similares
-
Kazinol B protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced cardiac injury by modulating the AKT/AMPK/Nrf2 signalling pathway
por: Zhang, Qian, et al.
Publicado: (2023) -
Paeoniflorin Protects H9c2 Cardiomyocytes against Hypoxia/Reoxygenation Induced Injury via Regulating the AMPK/Nrf2 Signaling Pathway
por: Yu, Wen, et al.
Publicado: (2022) -
CTRP13 Protects H9c2 Cells Against Hypoxia/Reoxygenation (H/R)-Induced Injury Via Regulating the AMPK/Nrf2/ARE Signaling Pathway
por: Jiang, Weifeng, et al.
Publicado: (2021) -
Retracted: Paeoniflorin Protects H9c2 Cardiomyocytes against Hypoxia/Reoxygenation Induced Injury via Regulating the AMPK/Nrf2 Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK
por: Tsai, Kun-Ling, et al.
Publicado: (2021)